CHELSIE TOLER BUCKLEY: Open Payments
NPI 1902573256 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,148 in 10 payments from 9 companies in 2025. Trend: 2023 $1,322 · 2024 $413 · 2025 $1,148
Food & beverage: $1,148
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $209 |
| Vanda Pharmaceuticals Inc. | 1 | $124 |
| Alkermes, Inc. | 1 | $124 |
| Neurocrine BioSciences, Inc. | 1 | $123 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| ABBVIE INC. | 1 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $118 |
| Braeburn Inc. | 1 | $108 |
| Gilead Sciences, Inc. | 1 | $102 |
Products named: Auvelity, FANAPT, VIVITROL, INGREZZA, ABILIFY MAINTENA, CAPLYTA, BRIXADI, Epclusa.
Industry payments across FL — which companies pay providers there.
